Katherin Patsch, PhD

Katherin Patsch is the Director, Drug Discovery at the Ellison Medical Institute. She works across research teams to develop a cancer drug discovery pipeline that supports innovative early discovery, mechanistic studies, and translational biology, to address unmet clinical needs.

The Institute addresses pressing challenges in cancer care through rigorous and rapid deployment of novel technologies to enhance clinical practice, diagnostics, and research. Along these lines, Dr. Patsch has developed a series of projects with select MPS technologies with the goal of enabling use in discovery and pre-clinical testing.

Dr. Patsch received her PhD in Molecular and Cell Biology from the Medical University of Innsbruck in Tyrol, Austria, where she studied cell signaling in regenerating muscle. In 2012, she joined the Institute to study androgen receptor dynamics using novel bi-directional functional assays. Her findings ultimately helped launch the Institute’s first drug discovery project.